Data as of May 21
| +0.28 / +2.62%|
AngioDynamics, Inc. provides innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. The company operates business through two segments: Vascular and Oncology/Surgery segment. The Vascular segment is responsible for products targeting the venous intervention, dialysis access, thrombus management and peripheral disease markets and has dedicated research & development and sales and marketing. The Oncology/Surgery segment is responsible for RF Ablation, embolization, Habib and NanoKnife product lines and has dedicated research & development and sales and marketing personnel. AngioDynamics was founded in 1988 by Eamonn P. Hobbs and is headquartered in Latham, NY.
|Joseph M. DeVivo||President, Chief Executive Officer & Director|
|George W. Bourne, MBA||SVP, Chief Technology & Operations Officer|
|Mark T. Frost||Chief Financial Officer & Executive Vice President|
|Donna Haire||SVP-Regulatory, Clinical & Medical Affairs|
|Louis J. Mazzarese||Chief Regulatory Officer & Senior Vice President|